News Search Results
Jul 01, 2025, 13:55 ET ISS National Lab Partners with AIAA to Expand ASCEND with Low Earth Orbit-Focused Sessions in 2025 and 2026
25 years of continuous human presence on the ISS and the valuable research the space station has enabled, including advancements in biotechnology, fundamental science, and technology development. At ASCEND, research teams and programmatic leaders will discuss the critical impact of the
More news about: International Space Station National Lab
Jul 01, 2025, 11:52 ET Transformer Services Market Size to Surpass USD 8.23 billion by 2031, at a CAGR of 6.9%, Experiences Growth Due to Increasing Demand for Electricity Across | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 01, 2025, 11:23 ET Global Market for Media, Sera, and Reagents in Biotechnology to Reach $9.3 Billion by 2029
is driving advances in biotechnology, diagnostics, and targeted therapies. Technological advances: Rapid technological advances are transforming industries by enhancing efficiency, innovation, and automation. These breakthroughs drive progress in biotechnology, healthcare, and other sectors,
More news about: BCC Research LLC
Jul 01, 2025, 11:15 ET Smart Infrastructure Market Size Projected to Hit USD 2,745.9 Billion at an 18.3% CAGR by 2031
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 01, 2025, 11:12 ET RS and Belden vanquish industrial cabling challenges
flex, bending, torsion, and random motion flex. This range is widely deployed in the automotive, industrial, machine tool, marine, medical, biotechnology, military, mining, petrochemical, semiconductor, solar, and wind power industries and well-suited for use in delta robots in addition to all the
More news about: RS
Jul 01, 2025, 10:45 ET Set-Top Box Market Size Set to Surpass USD 31.08 Billion by 2031, with CAGR of 3.1%, Rising Demand for High-Definition (HD) and Ultra-High-Definition (UHD) Content Propels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 01, 2025, 10:15 ET Biosimilars Market Size to Hit $76.2 Billion by 2030 - Driving Value-Based Care for Drugmakers, Regulators & Emerging Markets | The Research Insights
approximately 54.9%.Conclusion: The biosimilars market is undergoing a transformation driven by advancements in biotechnology, evolving regulatory landscapes, and expanding manufacturing capabilities. The increasing prevalence of chronic diseases and the rising economic
More news about: The Research Insights
Jul 01, 2025, 08:45 ET BioMarin Announces Completion of Acquisition of Inozyme
counsel to Inozyme since its founding, served as legal counsel. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Jul 01, 2025, 08:00 ET Apnimed to Participate in Upcoming July Investor Conferences
Evercore's Emerging Private Biotech ConferenceDate: July 13 - 15, 2025 Event: BTIG Virtual Biotechnology Conference 2025Date: July 29 - 30, 2025 Apnimed will be hosting 1x1 investor meetings around
More news about: Apnimed, Inc.
Jul 01, 2025, 08:00 ET Arthrosi Therapeutics Surpasses 50% Patient Enrollment in Replicate Pivotal Phase 3 REDUCE 1 Trial of Pozdeutinurad (AR882) in Patients with Gout, Including Those with Tophaceous Gout
DIEGO, July 1, 2025 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels,
More news about: Arthrosi Therapeutics
Jul 01, 2025, 07:30 ET Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jul 01, 2025, 07:17 ET Nektar Therapeutics Announces Pricing of $100 Million Public Offering
July 1, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its underwritten public
More news about: Nektar Therapeutics
Jul 01, 2025, 07:00 ET Frontage Announces Expansion of Business in Canada with New Leadership
provider of comprehensive, high-quality R&D services, supporting Canada's vision to become a dynamic hub for biotechnology and pharmaceutical innovation." About Frontage (
More news about: Frontage Laboratories, Inc.
Jul 01, 2025, 06:30 ET Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform
Sana Biotechnology (NASDAQ: SANA),
More news about: Flagship Pioneering
Jul 01, 2025, 01:40 ET HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach
July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, today announces the signing of a major out-licensing agreement
More news about: HanchorBio Inc.
Jun 30, 2025, 17:31 ET GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion | DelveInsight
highly targeted therapies. Pharmaceutical companies are increasingly investing in GPCR-focused pipelines, often in collaboration with biotechnology firms and academic research institutions. Strategic partnerships, licensing deals, and acquisitions are common, aiming to access novel chemistries
More news about: DelveInsight Business Research, LLP
Jun 30, 2025, 16:38 ET Announcement of fully underwritten rights issue
www.bergenbio.com About Oncoinvent ASA Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide
More news about: Oncoinvent AS
Jun 30, 2025, 16:36 ET Announcement of fully underwritten rights issue
www.bergenbio.com About Oncoinvent ASA Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide
More news about: Oncoinvent AS
Jun 30, 2025, 16:31 ET BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
field, improving the lives of patients with cancer in the peritoneal cavity." About Oncoinvent Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting
More news about: Oncoinvent AS
Jun 30, 2025, 16:28 ET BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
field, improving the lives of patients with cancer in the peritoneal cavity." About Oncoinvent Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting
More news about: Oncoinvent AS
Jun 30, 2025, 16:05 ET Halozyme Therapeutics Added to Russell 1000® Index
one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Jun 30, 2025, 16:02 ET Nektar Therapeutics Announces Proposed Public Offering
June 30, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced that it has commenced an underwritten
More news about: Nektar Therapeutics
Jun 30, 2025, 15:00 ET Marine Collagen Market to Reach $2.32 Billion by 2032, Driven by Cosmetics Industry Demand and Health Awareness, Says Meticulous Research®
Titan Biotech Limited, ITALGEL S.p.A., Amicogen Co. Ltd., BHN Co. Ltd., ConnOils LLC, HUM Nutrition Inc., Vital Proteins LLC, Hangzhou Nutrition Biotechnology Co. Ltd., and ETChem, focusing on sustainable sourcing practices, product innovation, and expansion into emerging markets. Request a customized
More news about: Meticulous Market Research Pvt. Ltd.
Jun 30, 2025, 14:25 ET Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®
Europe single-use bioreactors market is driven by rapid adoption of disposable technology in pharmaceutical and biotechnology industries, growing demand for biopharmaceuticals, substantial government support for bioproduction and biopharma products, and significant capacity
More news about: Meticulous Market Research Pvt. Ltd.
Jun 30, 2025, 14:14 ET North America LIMS Market to Reach $763.5 Million by 2032, Growing at a CAGR of 7.1% from 2025, Says Meticulous Research®
capabilities to meet the growing demand for efficient data management, regulatory compliance, and enhanced laboratory productivity across pharmaceutical, biotechnology, food & beverage, and environmental testing sectors. For more comprehensive insights, download the FREE report sample:
More news about: Meticulous Market Research Pvt. Ltd.